Atos Group shares fall nearly 10% over the week, among the weakest in the SBF 120
The IT services and cybersecurity group drops sharply mid-morning, in a Paris market that is also trending lower. An analyst rating was issued on the stock yesterday, and short positions remain at a high level.
A decline below all three moving averages, compounded by a weaker market
The stock loses 4.13% to €22.30 and ranks among the largest decliners in the SBF 120, while the index falls 1.04%. This session extends a sharp weekly decline of 9.57%.
The stock is now 11.33% below its 20-day moving average, erasing the ground regained in early November, when it was approaching its resistance at €27.78.
The support at €21.16 is about 5% below the current price. The Paris session remains under pressure: Atos is trading in a market weighed down by the correction in AI-related stocks on Wall Street, with the Nasdaq down 2.49% last night.
On the company side, the Atos Accenture consortium has been selected by the Assurance maladie (French national health insurance) to take over the management and digital security of the Shared Medical Record (Dossier Médical Partagé), an announcement published today that did not prevent the decline.
Short positions at 4.49% of share capital and €27 target from Kepler Cheuvreux
Five funds together hold 4.49% of the share capital sold short, according to the disclosures reviewed, up 0.81 points over one month. This level signals a more pronounced bearish positioning than in the autumn, although it is not possible to infer the intentions of market participants.
On the analyst side, Kepler Cheuvreux published a price target of €27 yesterday with a hold rating, implying a potential of nearly 21% relative to the current price.
When it published its third-quarter revenue on October 21, the group confirmed its objectives for fiscal year 2026. Over three months, the stock has declined 24.56%.